Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Cash from Investing Activities: 2019-2025

Historic Cash from Investing Activities for Fulcrum Therapeutics (FULC) over the last 7 years, with Sep 2025 value amounting to $18.6 million.

  • Fulcrum Therapeutics' Cash from Investing Activities rose 327.86% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.0 million, marking a year-over-year decrease of 29.58%. This contributed to the annual value of $32.2 million for FY2024, which is 187.84% up from last year.
  • Latest data reveals that Fulcrum Therapeutics reported Cash from Investing Activities of $18.6 million as of Q3 2025, which was up 33.58% from $13.9 million recorded in Q2 2025.
  • In the past 5 years, Fulcrum Therapeutics' Cash from Investing Activities ranged from a high of $38.1 million in Q1 2024 and a low of -$106.6 million during Q3 2021.
  • For the 3-year period, Fulcrum Therapeutics' Cash from Investing Activities averaged around $2.5 million, with its median value being $13.9 million (2025).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first tumbled by 11,561.06% in 2021, then surged by 934.58% in 2023.
  • Fulcrum Therapeutics' Cash from Investing Activities (Quarterly) stood at -$9.1 million in 2021, then tumbled by 299.85% to -$36.4 million in 2022, then spiked by 150.48% to $18.4 million in 2023, then tumbled by 87.69% to $2.3 million in 2024, then skyrocketed by 327.86% to $18.6 million in 2025.
  • Its last three reported values are $18.6 million in Q3 2025, $13.9 million for Q2 2025, and -$777,000 during Q1 2025.